Put Options on DVA on 6/27/2022

DaVita Inc. (DVA)  provides kidney dialysis services for patients suffering from chronic kidney failure. 

The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.

As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients.  

On May 5th, Davita Healthcare Partners (DVA) reported 1st Quarter March 2022 earnings of $1.61 per share on revenue of $2.8 billion. The consensus earnings estimate was $1.85 per share on revenue of $2.9 billion. Since then, shares have formed a bearish flag and lower prices are expected for this stock.

We will be trading July 15th Put Options

Last Trade: $77.50

Trading Range: $74.97 - $136.48

Trade Buy 1 July $75.00 Put at $2.00 For a net debit of $2.00 Profit/Loss Analysis Breakeven at $73.00 Maximum profit is unbounded Maximum loss is ($200.00) at strike of $75.00 Closing Summary Sold 1 July $75.00 Put at $0.00

Position closed on 7/15/2022 at price of $0.00 with a -100.00% loss in 18 days.

Back to Portfolio